Related Experiment Video

Updated: Jan 14, 2026

Endocarditis IV: Nursing Management
01:29

Endocarditis IV: Nursing Management

Published on: June 19, 2025

314

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

D Aronson1, E J Rayfield, J H Chesebro

  • 1Joslin Diabetes Center, Boston, Massachusetts, USA.

Annals of Internal Medicine
|February 15, 1997
PubMed

Insights

Diabetic patients face higher mortality after myocardial infarction due to heart failure and thrombosis. However, current therapies for myocardial infarction remain effective, with improved metabolic control potentially further reducing risks.

Area of Science:

  • Cardiology
  • Diabetology
  • Pathophysiology

Background:

  • Diabetic patients exhibit poor prognosis following myocardial infarction (MI).
  • Understanding the mechanisms behind this increased mortality is crucial for developing targeted interventions.
  • Diabetic cardiomyopathy and accelerated atherosclerosis contribute to adverse outcomes.

Purpose of the Study:

  • To elucidate the pathogenic mechanisms driving poor prognosis in diabetic patients post-MI.
  • To evaluate the effectiveness of contemporary MI interventions in this patient population.

Main Methods:

  • Comprehensive literature search of MEDLINE (1985-1995) and relevant citations.
  • Inclusion of experimental, clinical, and basic research studies on diabetes and MI.
  • Keywords: diabetes, myocardial infarction, cardiomyopathy.

Main Results:

  • Excess in-hospital mortality in diabetics is linked to congestive heart failure, exacerbated by diabetic cardiomyopathy, coronary artery disease, and impaired vasodilation.
  • Late mortality is driven by reinfarction due to diffuse atherosclerosis, hypercoagulable state, and platelet hyperactivity.
  • Autonomic neuropathy increases the risk of ventricular arrhythmias.

Conclusions:

  • Diabetic patients have 1.5-2 times higher mortality post-MI compared to non-diabetics, attributed to complex pathophysiological mechanisms.
  • Current MI therapies, including thrombolytics, aspirin, beta-blockers, and ACE inhibitors, are effective in diabetic patients.
  • Enhanced glycemic control may further improve survival rates in diabetic individuals post-MI.
Abstract

More Related Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Published on: June 19, 2025

382
Increased Body Temperature01:25

Increased Body Temperature

6.4K

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
314
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
382
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
6.4K
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.2K
Homeostatic Imbalances in Body Temperature01:19

Homeostatic Imbalances in Body Temperature

Hyperthermia occurs when the body's temperature becomes unusually high, often due to heat exposure, intense physical activity, or certain illnesses. This condition can create a dangerous cycle where elevated body temperature increases the metabolic rate, generating more heat and potentially leading to organ failure and brain damage. A severe form of hyperthermia, called heat stroke, can raise body temperature to life-threatening levels. Fever, on the other hand, is a controlled form of...
4.3K